Journal list Promote Sponsor
verified SJR 1,37 · Q1 • database Scopus / SJR & Web of Science indexed
International Psychogeriatrics
United States · Elsevier Inc.
workspace_premium Q1 — Psychiatry and Mental Health lock_open Open Access

International Psychogeriatrics

International Psychogeriatrics is a journal indexed in SJR in Psychiatry and Mental Health and Clinical Psychology with an H index of 126. It has a price of 1626.56 €. It has an SJR impact factor of 1,37 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,37.

International Psychogeriatrics focuses its scope in these topics and keywords: dementia, cognitive, depression, older, anxiety, mild, disease, nursing, living, impairment, ...

ISSN: 1041-6102
Publisher: Elsevier Inc.
Category: Psychiatry and Mental Health
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Visit publisher site menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,37 Q1
H-index 126
Acceptance rate pie_chart
24% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
1.627 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,37

H-index

126

Docs (year)

149

Docs 3y

424

Total refs

4913

Cites 3y

1103

Citable 3y

227

Cites/Doc 2y

2.61

Ref/Doc

32.97

Immediate OA

1626.56 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Butyrylcholinesterase and Cognitive Function

View more

What should we be teaching medical students about dementia?

View more

Dementia in Developing Countries

View more

Dementia

View more

Defining Parkinsonism in the Canadian Study of Health and Aging

View more

Data Collected in the Canadian Study of Health and Aging

View more

Correlates of Nonparticipation in the Canadian Study of Health and Aging

View more

Conventional Neuroleptics in Dementia

View more

Comparison of Alzheimer's Disease in Native Americans and Whites

View more

Cognitively Impaired Older Adults: Risk Profiles for Institutionalization

View more

Cognitive Impairment, No Dementia: Concepts and Issues

View more

Cholinergic Contributions to Behavioral Disturbances in Alzheimer's Disease

View more
SHOW MORE ARTICLES

Characteristics of an Ideal Drug for Behavioral and Psychological Symptoms of Dementia

View more

A Bumpy Bumper Year

View more

Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards

View more

Behavioral and Psychological Symptoms of Dementia and Vascular Dementia

View more

Behavioral and Psychological Symptoms of Dementia and Dementia With Lewy Bodies

View more

Behavioral and Psychological Symptoms of Dementia (BPSD) and Delirium

View more

Behavioral and Psychological Symptoms and Frontotemporal Dementia (Pick's Disease)

View more

Assessing Hypertension in the Canadian Study of Health and Aging

View more

Anticonvulsants to Treat Agitation in Dementia

View more

Alzheimer's Disease and Other Dementia in Nursing Homes: Levels of Management and Cost

View more

Agitation in Chinese Elderly: Validation of the Chinese Version of the Cohen-Mansfield Agitation Inventory

View more

Ageism and caring attitudes among nurses in oncology

View more

FAQs